Ian Nicholson is Chair of the Remuneration Committee. Ian has over 35 years’ international experience in management and transactions within the life sciences sector including as chairman of Bioventix plc, as operating partner at London-based Advent Life Sciences LLP, and 8 years as CEO of the privately held anti-fungal drug development company F2G Limited. Ian has worked extensively in licensing, mergers and acquisitions and market development in the UK, Europe and the USA.
Ian Nicholson
Latest news
-
LifeArc joins transatlantic collaboration to develop a treatment for Crimean-Congo Hemorrhagic Fever
-
LifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing
-
£1 million partnership aims to develop new treatments for congenital muscular dystrophy